Investors in "full bull" mode as vaccine hopes run high - BofA survey

The euphoria sent investors' cash levels down to 4.1% in November, from 4.4% last month, to pre-COVID-19 levels last seen in January, according to the survey of 190 fund managers with $526 billion in assets under management.

Getty Images
We say 'sell the vaccine' in coming weeks/months as we think we're close to 'full bull
Investors are in "full bull" mode, deploying more money into emerging markets, small-cap stocks and the banking sector on hopes a COVID-19 vaccine will turn around these hard-hit market segments, BofA's monthly investor survey showed on Tuesday.

The euphoria sent investors' cash levels down to 4.1% in November, from 4.4% last month, to pre-COVID-19 levels last seen in January, according to the survey of 190 fund managers with $526 billion in assets under management.

With global economic growth and profit expectations running at a 20-year high among the investors surveyed, the "reopening rotation" into oversold business sectors is likely to continue in the fourth quarter, BofA said.


But the bank advised clients: "We say 'sell the vaccine' in coming weeks/months as we think we're close to 'full bull'."

Meanwhile in U.S. Treasuries, 73% of the investors surveyed were expecting steeper yield curves -- rates on longer-term U.S. Treasury securities rising faster than short-term rates. Expectations were far higher than after the 2008 Lehman bankruptcy, 2013 taper tantrum and 2016 elections.

For 2021, investors named being "long" emerging market assets, S&P 500 and oil as their favourite trades.
ADVERTISEMENT
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › News › Investors in "full bull" mode as vaccine hopes run high - BofA survey
Text Size:AAA
Success
This article has been saved

*

+